The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic

作者: Barbara B Fleming , Sheldon Greenfield , Michael M Engelgau , Leonard M Pogach , None

DOI: 10.2337/DIACARE.24.10.1815

关键词: Health careEvidence-based medicineQuality managementPublic healthHealth policyGerontologyPsychological interventionHealth promotionQuality (business)MedicineMedical emergency

摘要: As the worldwide diabetes epidemic continues to unfold, some experts have asked whether war against it is being lost (1,2,3). In U.S., blindness, kidney failure, amputations, and cardiovascular disease resulting from not only markedly reduce quality length of life but also cost nearly $100 billion annually (4,5,6,7). Fortunately, a vast body research has clearly established that several effective treatments practices may substantially or prevent this burden (8,9,10,11,12,13,14,15,16,17,18,19). These interventions, if broadly implemented, can allow us use our health efforts resources more effectively efficiently minimize burden. Judging scant data available, however, level care currently delivered populations with often produce possible health-related gains (20,21). To assess completely in we need standardized uniform performance measures accurately reliably. will enhance uptake into practice ultimately improve clinical outcomes. early mid-1990s, many organizations developed for care, result was providers were required collect report different, sometimes conflicting, measures, depending on their delivery system. It recognized national consensus could process provide method assessing within across settings while providing meaningful mechanism improvement (QI). review, describe Diabetes Quality Improvement Project (DQIP), which implemented comprehensive set evaluation …

参考文章(26)
UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)
R. C. Eastman, J. C. Javitt, W. H. Herman, E. J. Dasbach, C. Copley-Merriman, W. Maier, F. Dong, D. Manninen, A. S. Zbrozek, J. Kotsanos, S. A. Garfield, M. Harris, Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia Diabetes Care. ,vol. 20, pp. 735- 744 ,(1997) , 10.2337/DIACARE.20.5.735
G. L. Beckles, M. M. Engelgau, K. V. Narayan, W. H. Herman, R. E. Aubert, D. F. Williamson, Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S Diabetes Care. ,vol. 21, pp. 1432- 1438 ,(1998) , 10.2337/DIACARE.21.9.1432
K. Pyorala, T. R. Pedersen, J. Kjekshus, O. Faergeman, A. G. Olsson, G. Thorgeirsson, , Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care. ,vol. 20, pp. 614- 620 ,(1997) , 10.2337/DIACARE.20.4.614
Stephen F. Jencks, Timothy Cuerdon, Dale R. Burwen, Barbara Fleming, Peter M. Houck, Annette E. Kussmaul, David S. Nilasena, Diana L. Ordin, David R. Arday, Quality of Medical Care Delivered to Medicare Beneficiaries JAMA. ,vol. 284, pp. 1670- 1676 ,(2000) , 10.1001/JAMA.284.13.1670
M. A. Safran, F. Vinicor, The war against diabetes. How will we know if we are winning Diabetes Care. ,vol. 22, pp. 508- 516 ,(1999) , 10.2337/DIACARE.22.3.508
H. King, R. E. Aubert, W. H. Herman, Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections Diabetes Care. ,vol. 21, pp. 1414- 1431 ,(1998) , 10.2337/DIACARE.21.9.1414